trametinib,dabrafenib
novartis
['trametinib', 'dabrafenib']
 such an honor to be a part of a major milesone in #precisionmedicine #aacr23 1/10 this practice changing tissue agnostic study published in led to fda approval of dabrafenib+ trametinib in braf v600+ cancers. this is the ultimate result of work of 
Oncologist | Associate Prof | Executive Director-Research, MD Anderson Cancer Network | Medical Director, Clinical Center for Targeted Therapy. Tweets = my own.